Nautilus Biotechnolgy Financial Overview
Nautilus Biotechnolgy's market cap is currently $250.08M. The company's EPS TTM is $-0.11; its P/E ratio is -3.91; Nautilus Biotechnolgy is scheduled to report earnings on October 28, 2025, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.
